| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000023460 |
| Receipt No. | R000027033 |
| Official scientific title of the study | The efficacy and safety of perioperative blood glucose management using artificial pancreas in patients with hepato-pancreato-biliary surgery |
| Date of disclosure of the study information | 2016/08/05 |
| Last modified on | 2019/03/05 (Ver. 6) |
| Basic information | ||
| Official scientific title of the study | The efficacy and safety of perioperative blood glucose management using artificial pancreas in patients with hepato-pancreato-biliary surgery | |
| Title of the study (Brief title) | The efficacy and safety of perioperative blood glucose management using artificial pancreas | |
| Region |
|
|
| Condition | |||
| Condition | Hepatectomy above 1 sector
Pancreatoduodenectomy Distal pancreatectomy |
||
| Classification by specialty |
|
||
| Classification by malignancy | Malignancy | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To confirm the safety (hypoglycemic attack) and efficacy (postoperative complications and hospital days) |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | The incidence of postoperative complications |
| Key secondary outcomes | 1) Perioperative blood glucose values, glycemic variability
2) Postoperative hospital days 3) inflammation-related factors |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Treatment Group (Target blood glucose range is from 80 to 110 mg/dl) | |
| Interventions/Control_2 | Control Group (Target blood glucose range is from 80 to 180 mg/dl) | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) Patients received following surgery
a) Hepatectomy above 1 sector b) Pancreatoduodenectomy c) Distal pancreatectomy 2) ECOG Performance Status Scale: 0-1 3) Patients with impaired glucose tolerance 4) Age between 20 y.o. to 85 y.o. |
|||
| Key exclusion criteria | 1)Patients with severe respiratory disease
2)Dialysis patients with chronic renal failure 3)Other inadequate case judged by study participated doctor |
|||
| Target sample size | 20 | |||
| Research contact person | |
| Name of lead principal investigator | Hiroya Akabori |
| Organization | Shiga University of Medical Science |
| Division name | Department of Surgery |
| Address | Seta Tsukinowa-cho, Otsu, Shiga |
| TEL | 077-548-2238 |
| hakabori@belle.shiga-med.ac.jp | |
| Public contact | |
| Name of contact person | Hiroya Akabori |
| Organization | Shiga University of Medical Science |
| Division name | Department of Surgery |
| Address | Seta Tsukinowa-cho, Otsu, Shiga |
| TEL | 077-548-2238 |
| Homepage URL | |
| hakabori@belle.shiga-med.ac.jp | |
| Sponsor | |
| Institute | Shiga University of Medical Science |
| Institute | |
| Department | |
| Funding Source | |
| Organization | NIKKISO CO,.LTD |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000027033 |